Viewing Study NCT00864032


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2026-03-06 @ 1:35 PM
Study NCT ID: NCT00864032
Status: COMPLETED
Last Update Posted: 2013-04-10
First Post: 2009-03-17
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall
Sponsor: University of California, Davis
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: STS Sorafenib
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View